Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Warren Buffett’s Best Mid-Cap Picks: DaVita HealthCare Partners Inc (DVA), Verisign, Inc. (VRSN), Chicago Bridge & Iron Company N.V. (CBI)

Page 1 of 2

As per the records of Forbes, Warren Buffett ranks fourth on the list of the richest billionaires in the world with a net worth of $71.3 billion. Buffett has amassed most of that wealth through running Berkshire Hathaway, the financial holding company which boasts an equity portfolio of $107.13 billion. The entire investment community keeps a close eye on the stock picks of Buffett and we’ll look at some of them today, specifically some of his mid-cap picks, which include DaVita HealthCare Partners Inc (NYSE:DVA), Verisign, Inc. (NASDAQ:VRSN) and M&T Bank Corporation (NYSE:MTB).

Warren Buffett

Why are we interested in the 13F filings of a select group of hedge funds? We use these filings to determine the top 15 small-cap stocks held by these elite funds based on 16 years of research that showed their top small-cap picks are much more profitable than both their large-cap stocks and the broader market as a whole. These small-cap stocks beat the S&P 500 Total Return Index by an average of nearly one percentage point per month in our backtests, which were conducted over the period of 1999 to 2012. Moreover, since the beginning of forward testing from August 2012, the strategy worked just as our research predicted, outperforming the market every year and returning 139% over the last 32 months, which is more than 80 percentage points higher than the returns of the S&P 500 ETF (SPY) (see more details).

DaVita HealthCare Partners Inc (NYSE:DVA) is the largest mid-cap stock holding of Warren Buffett, who owns 38.57 million shares valued at $3.13 billion. According to recent research from Novus, the long exposure of hedge funds in health care rose up to $289.67 billion in the first quarter of 2015 as the industry continues to perform strongly. The shares of DaVita HealthCare Partners Inc (NYSE:DVA) have been no different, having gained a solid 10.51% this year, pushing the kidney service provider’s market cap to $18.00 billion. In its latest quarterly financial results, the health care company met the expectations of the market with revenue of $3.29 billion against market estimates of $3.25 billion; revenue was also an improvement of 8.1% year-over-year. DaVita also reported EPS of $0.86 for the quarter, which was consistent with the market expectations. Andreas Halvorsen‘s Viking Global and Lone Pine Capital are major stockholders of DaVita HealthCare Partners Inc (NYSE:DVA).

Warren Buffett’s equity portfolio holds 12.99 million shares of Verisign, Inc. (NASDAQ:VRSN) valued at $869.61 million and it accounts for 0.81% of the overall value of the equity portfolio. Verisign, Inc. (NASDAQ:VRSN) has a market cap of $7.52 billion, fueled by its shares’ improvement of 12.47% in 2015. The shares of domain name provider are trading at $64.61, which is 5.30% lower than its 52-week high, with a P/E ratio of 25.43. The first quarter results of Verisign, Inc. (NASDAQ:VRSN) were aligned with the market’s expectations as the company reported EPS of $0.69, which was $0.15 higher than the first quarter of 2014. The quant funds Renaissance Technologies and D E Shaw each hold major stakes in the domain name provider.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!